204 related articles for article (PubMed ID: 28793277)
1. O-(2-
Imperiale A; Boisson F; Kreutter G; Goichot B; Namer IJ; Bachellier P; Laquerriere P; Kessler L; Marchand P; Brasse D
Nucl Med Biol; 2017 Oct; 53():21-28. PubMed ID: 28793277
[TBL] [Abstract][Full Text] [Related]
2. Effect of Carbidopa on 18F-FDOPA Uptake in Insulinoma: From Cell Culture to Small-Animal PET Imaging.
Detour J; Pierre A; Boisson F; Kreutter G; Lavaux T; Namer IJ; Kessler L; Brasse D; Marchand P; Imperiale A
J Nucl Med; 2017 Jan; 58(1):36-41. PubMed ID: 27609787
[TBL] [Abstract][Full Text] [Related]
3. Early
Leroy-Freschini B; Amodru V; Addeo P; Sebag F; Vix M; Brunaud L; Klein M; Bahougne T; Bachellier P; Castinetti F; Goichot B; Chevalier E; Taieb D; Imperiale A
Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):686-695. PubMed ID: 30617961
[TBL] [Abstract][Full Text] [Related]
4. 18F-FDOPA PET/CT imaging of insulinoma revisited.
Imperiale A; Sebag F; Vix M; Castinetti F; Kessler L; Moreau F; Bachellier P; Guillet B; Namer IJ; Mundler O; Taïeb D
Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):409-18. PubMed ID: 25367749
[TBL] [Abstract][Full Text] [Related]
5. Clinical Value of
Nakuz TS; Berger E; El-Rabadi K; Wadsak W; Haug A; Hacker M; Karanikas G
Anticancer Res; 2018 Jan; 38(1):353-358. PubMed ID: 29277794
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of ¹⁸F labeled FET prodrugs for tumor imaging.
Wang L; Lieberman BP; Ploessl K; Kung HF
Nucl Med Biol; 2014 Jan; 41(1):58-67. PubMed ID: 24183614
[TBL] [Abstract][Full Text] [Related]
7. Dynamic 18F-FDOPA PET Findings After Carbidopa Premedication in 2 Adult Patients With Insulinoma-Related Hyperinsulinemic Hypoglycemia.
Imperiale A; Bahougne T; Goichot B; Bachellier P; Taïeb D; Namer IJ
Clin Nucl Med; 2015 Aug; 40(8):682-4. PubMed ID: 25549347
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of
Yu J; Zheng J; Xu W; Weng J; Gao L; Tao L; Liang F; Zhang J
World Neurosurg; 2018 Jun; 114():e1211-e1224. PubMed ID: 29625311
[TBL] [Abstract][Full Text] [Related]
9. Role of O-(2-18F-fluoroethyl)-L-tyrosine PET as a diagnostic tool for detection of malignant progression in patients with low-grade glioma.
Galldiks N; Stoffels G; Ruge MI; Rapp M; Sabel M; Reifenberger G; Erdem Z; Shah NJ; Fink GR; Coenen HH; Langen KJ
J Nucl Med; 2013 Dec; 54(12):2046-54. PubMed ID: 24159047
[TBL] [Abstract][Full Text] [Related]
10. Limited value of 18F-F-DOPA PET to localize pancreatic insulin-secreting tumors in adults with hyperinsulinemic hypoglycemia.
Tessonnier L; Sebag F; Ghander C; De Micco C; Reynaud R; Palazzo FF; Conte-Devolx B; Henry JF; Mundler O; Taïeb D
J Clin Endocrinol Metab; 2010 Jan; 95(1):303-7. PubMed ID: 19915018
[TBL] [Abstract][Full Text] [Related]
11. Role of O-(2-(18)F-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis.
Galldiks N; Stoffels G; Filss CP; Piroth MD; Sabel M; Ruge MI; Herzog H; Shah NJ; Fink GR; Coenen HH; Langen KJ
J Nucl Med; 2012 Sep; 53(9):1367-74. PubMed ID: 22872742
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.
Wang HE; Wu SY; Chang CW; Liu RS; Hwang LC; Lee TW; Chen JC; Hwang JJ
Nucl Med Biol; 2005 May; 32(4):367-75. PubMed ID: 15878506
[TBL] [Abstract][Full Text] [Related]
13. PET of insulinoma using ¹⁸F-FBEM-EM3106B, a new GLP-1 analogue.
Gao H; Niu G; Yang M; Quan Q; Ma Y; Murage EN; Ahn JM; Kiesewetter DO; Chen X
Mol Pharm; 2011 Oct; 8(5):1775-82. PubMed ID: 21800885
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients.
Lapa C; Linsenmann T; Monoranu CM; Samnick S; Buck AK; Bluemel C; Czernin J; Kessler AF; Homola GA; Ernestus RI; Löhr M; Herrmann K
J Nucl Med; 2014 Oct; 55(10):1611-6. PubMed ID: 25125481
[TBL] [Abstract][Full Text] [Related]
15. Serial 18F-FET PET Imaging of Primarily 18F-FET-Negative Glioma: Does It Make Sense?
Unterrainer M; Schweisthal F; Suchorska B; Wenter V; Schmid-Tannwald C; Fendler WP; Schüller U; Bartenstein P; Tonn JC; Albert NL
J Nucl Med; 2016 Aug; 57(8):1177-82. PubMed ID: 27033893
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging.
Wester HJ; Herz M; Weber W; Heiss P; Senekowitsch-Schmidtke R; Schwaiger M; Stöcklin G
J Nucl Med; 1999 Jan; 40(1):205-12. PubMed ID: 9935078
[TBL] [Abstract][Full Text] [Related]
17. Imaging Melphalan Therapy Response in Preclinical Extramedullary Multiple Myeloma with
Hathi DK; DeLassus EN; Achilefu S; McConathy J; Shokeen M
J Nucl Med; 2018 Oct; 59(10):1551-1557. PubMed ID: 29700126
[TBL] [Abstract][Full Text] [Related]
18.
Unterrainer M; Galldiks N; Suchorska B; Kowalew LC; Wenter V; Schmid-Tannwald C; Niyazi M; Bartenstein P; Langen KJ; Albert NL
J Nucl Med; 2017 Apr; 58(4):584-589. PubMed ID: 27754904
[TBL] [Abstract][Full Text] [Related]
19. The use of dynamic O-(2-18F-fluoroethyl)-l-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma.
Galldiks N; Stoffels G; Filss C; Rapp M; Blau T; Tscherpel C; Ceccon G; Dunkl V; Weinzierl M; Stoffel M; Sabel M; Fink GR; Shah NJ; Langen KJ
Neuro Oncol; 2015 Sep; 17(9):1293-300. PubMed ID: 26008606
[TBL] [Abstract][Full Text] [Related]
20. Uptake of O-(2-[18F]fluoroethyl)-L-tyrosine in reactive astrocytosis in the vicinity of cerebral gliomas.
Piroth MD; Prasath J; Willuweit A; Stoffels G; Sellhaus B; van Osterhout A; Geisler S; Shah NJ; Eble MJ; Coenen HH; Langen KJ
Nucl Med Biol; 2013 Aug; 40(6):795-800. PubMed ID: 23769262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
